Prevention of Graves’ ophthalmopathy
- 1 June 2012
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 26 (3) , 371-379
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Pathogenesis of Graves’ orbitopathy: A 2010 updateJournal of Endocrinological Investigation, 2010
- Graves' OphthalmopathyNew England Journal of Medicine, 2010
- Graves' OphthalmopathyNew England Journal of Medicine, 2009
- Influence of the TSH Receptor Gene on Susceptibility to Graves' Disease and Graves' OphthalmopathyThyroid®, 2008
- Interleukin (IL)-23 Receptor Is a Major Susceptibility Gene for Graves’ Ophthalmopathy: The IL-23/T-helper 17 Axis Extends to Thyroid AutoimmunityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Intercellular Adhesion Molecule 1 Gene Polymorphisms in Graves’ DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populationsEuropean Journal of Endocrinology, 2003
- Epidemiology and Prevention of Graves' OphthalmopathyThyroid®, 2002
- Graves' ophthalmopathy: a preventable disease?European Journal of Endocrinology, 2002
- Natural history of thyroid associated ophthalmopathyClinical Endocrinology, 1995